News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
AKKARAJU SRINIVAS
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Disposed/sold 3,300 shares
@ $0
Disposed/sold 5,161,888 shares
@ $0
Disposed/sold 23,522 options to buy
@ $14.77, valued at
$347.4k
Disposed/sold 5,948 options to buy
@ $16.81, valued at
$100k
Disposed/sold 13,300 options to buy
@ $13.88, valued at
$184.6k
|
|
| 06/02/2023 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 6,000 options to buy
@ $3.7, valued at
$22.2k
Granted 4,000 restricted stock units
@ $0 |
|
| 05/31/2023 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Exercised 3,300 restricted stock units
@ $0 |
|
| 05/25/2023 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 8,111 shares
@ $0
Granted 12,547 options to buy
@ $9.17, valued at
$115.1k
|
|
| 04/20/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2023 |
3
| AKKARAJU SRINIVAS (10% Owner) has filed a Form 3 on Mineralys Therapeutics, Inc. |
| 09/23/2022 |
4
| AKKARAJU SRINIVAS (10% Owner) has filed a Form 4 on Jiya Acquisition Corp.|
Txns:
| Acquired 29,667 options to buy
@ $0 |
|
| 09/20/2022 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on Scholar Rock Holding Corp|
Txns:
| Granted 56,000 options to buy
@ $8.91, valued at
$499k
|
|
| 09/19/2022 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 12,000 options to buy
@ $7.349, valued at
$88.2k
Granted 8,000 restricted stock units
@ $0 |
|
| 07/28/2022 |
3
| AKKARAJU SRINIVAS (Director) has filed a Form 3 on Scholar Rock Holding Corp |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2022 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Bought 570,000 shares
@ $14, valued at
$8M
|
|
| 05/31/2022 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Granted 13,300 options to buy
@ $13.88, valued at
$184.6k
Granted 3,300 restricted stock units
@ $0 |
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2022 |
4
| Samsara BioCapital, L.P. (10% Owner) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Bought 74,464 shares
@ $4.07, valued at
$303.1k
Bought 350,000 shares
@ $4.08, valued at
$1.4M
|
|
| 01/25/2022 |
4
| Samsara BioCapital, L.P. (10% Owner) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Bought 100,000 shares
@ $8.99, valued at
$899k
Bought 23,000 shares
@ $8.7, valued at
$200.1k
|
|
| 01/21/2022 |
4
| Samsara BioCapital, L.P. (10% Owner) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Bought 54,565 shares
@ $9.24, valued at
$504.2k
Bought 43,105 shares
@ $8.92, valued at
$384.5k
|
|
| 12/20/2021 |
4
| Samsara BioCapital, L.P. (10% Owner) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Bought 22,329 shares
@ $10.19, valued at
$227.5k
|
|
| 11/24/2021 |
4
| Samsara BioCapital, L.P. (10% Owner) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Bought 201,685 shares
@ $10.15, valued at
$2M
|
|
| 11/17/2021 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Bought 1,215,000 shares
@ $14, valued at
$17M
|
|
| 10/15/2021 |
4
| Samsara BioCapital, L.P. (10% Owner) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Bought 45,400 shares
@ $13.22, valued at
$600.2k
Bought 3,100 shares
@ $12.5, valued at
$38.8k
Bought 2,300 shares
@ $12.49, valued at
$28.7k
|
|
| 10/08/2021 |
4
| Samsara BioCapital, L.P. (10% Owner) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Bought 61,475 shares
@ $13.83, valued at
$850.2k
Bought 9,021 shares
@ $14.94, valued at
$134.8k
Bought 75,000 shares
@ $13.12, valued at
$984k
|
|
| 09/27/2021 |
4
| AKKARAJU SRINIVAS (10% Owner) has filed a Form 4 on Jiya Acquisition Corp.|
Txns:
| Acquired 30,000 options to buy
@ $0
Disposed of 30,000 options to buy
@ $0 |
|
| 08/30/2021 |
4
| AKKARAJU SRINIVAS (10% Owner) has filed a Form 4 on Jiya Acquisition Corp.|
Txns:
| Disposed of 5,000 options to buy
@ $0 |
|
| 08/20/2021 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Bought 208,500 shares
@ $11.98, valued at
$2.5M
|
|
| 07/01/2021 |
4
| Samsara BioCapital, L.P. (10% Owner) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Converted 6,167,763 shares
@ $0
Converted 741,107 shares
@ $0
Converted 22,753 shares
@ $0
Bought 485,000 shares
@ $17, valued at
$8.2M
Bought 15,000 shares
@ $17, valued at
$255k
Converted 15,000,000 options to buy
@ $0
Converted 1,802,372 options to buy
@ $0
Converted 55,336 options to buy
@ $0 |
|
| 06/24/2021 |
3
| Samsara BioCapital, L.P. (10% Owner) has filed a Form 3 on Graphite Bio, Inc. |
| 06/10/2021 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $6.3, valued at
$110.3k
|
|
| 06/08/2021 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Granted 5,948 options to buy
@ $16.81, valued at
$100k
|
|
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2021 |
4
| AKKARAJU SRINIVAS (10% Owner) has filed a Form 4 on Jiya Acquisition Corp.|
Txns:
| Disposed of 5,000 options to buy
@ $0 |
|
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/11/2020 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 625,000 shares
@ $0
Granted 156,250 warrants
@ $11, valued at
$1.7M
|
|
|
|
|